Free Trial
NASDAQ:AMTX

Aemetis (AMTX) Stock Price, News & Analysis

Aemetis logo
$2.65 +0.36 (+15.72%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$2.69 +0.04 (+1.66%)
As of 10/3/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Aemetis Stock (NASDAQ:AMTX)

Advanced

Key Stats

Today's Range
$2.37
$2.87
50-Day Range
$2.15
$3.26
52-Week Range
$1.22
$4.73
Volume
4.66 million shs
Average Volume
806,200 shs
Market Capitalization
$167.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Moderate Buy

Company Overview

Aemetis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

AMTX MarketRank™: 

Aemetis scored higher than 38% of companies evaluated by MarketBeat, and ranked 210th out of 269 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aemetis has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Aemetis has a consensus price target of $17.00, representing about 541.5% upside from its current price of $2.65.

  • Amount of Analyst Coverage

    Aemetis has only been the subject of 1 research reports in the past 90 days.

  • Read more about Aemetis' stock forecast and price target.
  • Earnings Growth

    Earnings for Aemetis are expected to grow in the coming year, from ($2.07) to ($0.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aemetis is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aemetis is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Aemetis' valuation and earnings.
  • Percentage of Shares Shorted

    7.75% of the outstanding shares of Aemetis have been sold short.
  • Short Interest Ratio / Days to Cover

    Aemetis has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in Aemetis has recently increased by 5.38%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aemetis does not currently pay a dividend.

  • Dividend Growth

    Aemetis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.75% of the outstanding shares of Aemetis have been sold short.
  • Short Interest Ratio / Days to Cover

    Aemetis has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in Aemetis has recently increased by 5.38%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Aemetis has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Energy companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Aemetis this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for AMTX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aemetis insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $66,924.00 in company stock.

  • Percentage Held by Insiders

    14.70% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 27.02% of the stock of Aemetis is held by institutions.

  • Read more about Aemetis' insider trading history.
Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMTX Stock News Headlines

Aemelis Leaps on Newsom Nod
Gold surges past $3,600 … but this has beat gold by 1,000x
Gold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns.tc pixel
See More Headlines

AMTX Stock Analysis - Frequently Asked Questions

Aemetis' stock was trading at $2.69 at the beginning of the year. Since then, AMTX shares have decreased by 1.5% and is now trading at $2.65.

Aemetis, Inc (NASDAQ:AMTX) posted its quarterly earnings results on Thursday, August, 7th. The specialty chemicals company reported ($0.41) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by $0.06. The specialty chemicals company earned $52.24 million during the quarter, compared to the consensus estimate of $78.68 million.
Read the conference call transcript
.

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aemetis investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), American Water Works (AWK), The RMR Group (RMR), AU Optronics (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/07/2025
Today
10/03/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Energy
Industry
Biofuels
Sub-Industry
Chemicals
Current Symbol
NASDAQ:AMTX
CIK
738214
Employees
160
Year Founded
2006

Price Target and Rating

High Price Target
$28.00
Low Price Target
$3.00
Potential Upside/Downside
+541.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$87.54 million
Net Margins
-36.70%
Pretax Margin
-45.38%
Return on Equity
N/A
Return on Assets
-33.18%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.06
Quick Ratio
0.02

Sales & Book Value

Annual Sales
$267.64 million
Price / Sales
0.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($5.16) per share
Price / Book
-0.51

Miscellaneous

Outstanding Shares
63,240,000
Free Float
53,945,000
Market Cap
$167.59 million
Optionable
Optionable
Beta
1.68

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:AMTX) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners